Chiang J - Search Results

1

Pazopanib elicits remarkable response in metastatic porocarcinoma: a functional precision medicine approach.

Chan SPY, Low CE, Yau CE, Lin TP, Wang W, Xiu SX, Tang PY, Luo B, Noor NFBM, Lee KA, Chiang J, Toh TB, Chow EK, Yang VS. Chan SPY, et al. Among authors: chiang j. Cold Spring Harb Mol Case Stud. 2024 Jan 10;9(4):a006308. doi: 10.1101/mcs.a006308. Print 2023 Dec. Cold Spring Harb Mol Case Stud. 2024. PMID: 37945347 Free PMC article.

2

Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer Centre.

Chiang J, Yang VS, Han S, Zhuang Q, Ooi G, Sin IH, Chua GWY, Tan SY, Chia CS, Tan VK, Neo PSH, Kwek JW, Yap SP, Kanesvaran R, Lim ST, Hwang WYK, Tham CK. Chiang J, et al. J Cancer Policy. 2020 Sep;25:100241. doi: 10.1016/j.jcpo.2020.100241. Epub 2020 Jul 9. J Cancer Policy. 2020. PMID: 32834995 Free PMC article.

3

Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma.

Tan JY, Qiu TY, Chiang J, Tan YH, Yang VS, Chang EWY, Poon E, Somasundaram N, Farid M, Tao M, Lim ST, Chan JY. Tan JY, et al. Among authors: chiang j. J Hematol. 2021 Aug;10(4):187-195. doi: 10.14740/jh890. Epub 2021 Aug 30. J Hematol. 2021. PMID: 34527115 Free PMC article.

4

Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method.

Ng DZ, Lee CY, Lam WW, Tong AK, Tan SH, Khoo LP, Tan YH, Chiang J, Chang EW, Chan JY, Poon EY, Somasundaram N, Farid H Rashid M, Tao M, Lim ST, Yang VS. Ng DZ, et al. Among authors: chiang j. Leuk Lymphoma. 2022 Jan;63(1):256-259. doi: 10.1080/10428194.2021.1992624. Epub 2021 Oct 19. Leuk Lymphoma. 2022. PMID: 34665693

5

Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis.

Han S, Zhuang Q, Chiang J, Tan SH, Chua GWY, Xie C, Chua MLK, Soon YY, Yang VS. Han S, et al. Among authors: chiang j. BMJ Open. 2022 Feb 7;12(2):e044661. doi: 10.1136/bmjopen-2020-044661. BMJ Open. 2022. PMID: 35131810 Free PMC article.

6

Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy.

Tan JY, Qiu TY, Chiang J, Tan YH, Yang VS, Chang EWY, Poon E, Somasundaram N, Farid M, Tao M, Lim ST, Chan JY. Tan JY, et al. Among authors: chiang j. Leuk Lymphoma. 2023 Mar;64(3):586-596. doi: 10.1080/10428194.2022.2027402. Epub 2022 Feb 19. Leuk Lymphoma. 2023. PMID: 35188049

7

A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma.

Lo YT, Lim VY, Ng M, Tan YH, Chiang J, Chang EWY, Chan JY, Poon EYL, Somasundaram N, Bin Harunal Rashid MF, Tao M, Lim ST, Yang VS. Lo YT, et al. Among authors: chiang j. Cancers (Basel). 2022 Apr 3;14(7):1818. doi: 10.3390/cancers14071818. Cancers (Basel). 2022. PMID: 35406590 Free PMC article.

8

Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort study.

Teo YH, Teo YN, Khoo LP, Chang EWY, Tan YH, Chiang J, Yang VS, Poon E, Somasundaram N, Farid M, Tao M, Lim ST, Chan JY. Teo YH, et al. Among authors: chiang j. Leuk Lymphoma. 2022 Nov;63(11):2723-2726. doi: 10.1080/10428194.2022.2086242. Epub 2022 Jun 10. Leuk Lymphoma. 2022. PMID: 35687837 No abstract available.

9

Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant.

Soon Jian Hao J, Hoai CS, Weng DTS, Ngeow J, Chiang J. Soon Jian Hao J, et al. Among authors: chiang j. Cold Spring Harb Mol Case Stud. 2022 Dec 28;8(7):a006223. doi: 10.1101/mcs.a006223. Print 2022 Dec. Cold Spring Harb Mol Case Stud. 2022. PMID: 36577523 Free PMC article.

10

Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin's Lymphoma.

Tan GF, Goh S, Chang EWY, Tan YH, Chiang J, Yang VS, Poon EYL, Somasundaram N, Bin Harunal Rashid MF, Tao M, Lim ST, Ong CK, Chan JY. Tan GF, et al. Among authors: chiang j. Hematol Rep. 2023 Feb 10;15(1):108-118. doi: 10.3390/hematolrep15010012. Hematol Rep. 2023. PMID: 36810555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,649 results

Search Page